Literature DB >> 8673489

Focal upper limb demyelinating neuropathy.

P K Thomas1, D Claus, A Jaspert, J M Workman, R H King, A J Larner, M Anderson, J A Emerson, I T Ferguson.   

Abstract

Observations are presented on nine selected patients with chronic upper limb demyelinating neuropathy to illustrate the range of manifestations that may be observed. In three, the involvement was purely motor, in five, mixed motor and sensory and, in one, virtually purely sensory; in seven the symptoms were unilateral and in two bilateral. The presence of reduced nerve conduction velocity and conduction block and the response to treatment in seven of the cases indicate that they represented examples of chronic inflammatory demyelinating polyneuropathy (CIDP) with focal involvement. This was confirmed by nerve biopsy in two cases. The presentation in one patient was accompanied by forearm swelling initially suspected of being a tumour but shown to be due to muscle hypertrophy. This was probably the consequence of recurrent muscle cramps and fasciculation and possibly neuromyotonia. The patient with predominant sensory involvement restricted to the upper limbs demonstrates that sensory CIDP can present focally. In one patient with monomelic motor and sensory involvement, nerve biopsy showed multifocal areas of hypertrophic demyelinating neuropathy distally in the ulnar nerve without inflammatory infiltration. This patient failed to respond to therapy. Response in the others was satisfactory, although one patient with a monomelic motor neuropathy showed a severe deterioration after being given corticosteroids; he subsequently improved with intravenous human immunoglobulin therapy.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8673489     DOI: 10.1093/brain/119.3.765

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  17 in total

1.  Multifocal acquired demyelinating sensory and motor neuropathy.

Authors:  Araya Puwanant; David N Herrmann
Journal:  Neurology       Date:  2012-10-16       Impact factor: 9.910

Review 2.  Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy.

Authors:  Mohamed Mahdi-Rogers; Ruth Brassington; Angela A Gunn; Pieter A van Doorn; Richard Ac Hughes
Journal:  Cochrane Database Syst Rev       Date:  2017-05-08

3.  Magnetic resonance imaging in bilateral brachial neuritis with pure sensory involvement.

Authors:  Sibel Gazioglu; Cavit Boz; Ahmet Sarı
Journal:  Neurol Sci       Date:  2011-11-24       Impact factor: 3.307

Review 4.  Brain metastases: epidemiology and pathophysiology.

Authors:  Igor T Gavrilovic; Jerome B Posner
Journal:  J Neurooncol       Date:  2005-10       Impact factor: 4.130

5.  Distribution patterns of demyelination correlate with clinical profiles in chronic inflammatory demyelinating polyneuropathy.

Authors:  S Kuwabara; K Ogawara; S Misawa; M Mori; T Hattori
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-01       Impact factor: 10.154

Review 6.  Systematic reviews of treatment for inflammatory demyelinating neuropathy.

Authors:  R A C Hughes
Journal:  J Anat       Date:  2002-04       Impact factor: 2.610

7.  Chronic inflammatory demyelinating polyneuropathy.

Authors:  Mazen M Dimachkie; Richard J Barohn
Journal:  Curr Treat Options Neurol       Date:  2013-06       Impact factor: 3.598

8.  Predominant Upper Limb Chronic Demyelinating Polyneuropathy Associated with HBV Infection.

Authors:  Ioan-Cristian Lupescu; Adriana Octaviana Dulamea
Journal:  Maedica (Bucur)       Date:  2017-12

Review 9.  Multifocal motor neuropathy, multifocal acquired demyelinating sensory and motor neuropathy, and other chronic acquired demyelinating polyneuropathy variants.

Authors:  Mazen M Dimachkie; Richard J Barohn; Jonathan Katz
Journal:  Neurol Clin       Date:  2013-02-16       Impact factor: 3.806

Review 10.  Association between chronic inflammatory demyelinating polyneuropathy and gastrointestinal malignancies.

Authors:  Adnan Malik; Rani Berry; Brian M Fung; James H Tabibian
Journal:  Clin J Gastroenterol       Date:  2020-11-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.